|
17-May-12
During the 7th Annual Community Oncology Conference, Dr. Howard Burris III talked about MET inhibitors, "a fascinating new class of anti-cancer agents." He also talked about what community oncologists can do to increase participation...
|
|
|
30-Apr-12
Lung cancer is no longer treated as a monolithic illness, according Dr. Corey J. Langer, director of thoracic oncology at Abrahamson Cancer Center at the University of Pennsylvania, Philadelphia. In this interview, he discusses the impact...
|
|
|
08-Apr-12
During the 7th Annual Community Oncology Conference, Dr. Howard "Skip" Burris III talked about MET inhibitors, "a fascinating new class of anti-cancer agents." He also talked about what community oncologists can do to increase...
|
|
Lancet Press Conference on Colorectal Cancer Screening
27-Apr-10
In new research published in The Lancet, researchers announce findings of a UK-based trial, which started 16 years ago, to assess the merit (in terms of reduction in mortality and incidence) of a single sigmoidoscopy examination in patients aged...
|
The 2nd Asian Oncology Summit - pre-Summit podcast
17-Mar-10
An interview with Dr David Collingridge, Professor Werner Burkart (Deputy Director General, Head of Department of Nuclear Sciences and Applications, International Atomic Energy Agency), and Professor Bruce Mann (President, Clinical Oncological...
|
Delivering consensus from the Asian Oncology Summit 2009
02-Nov-09
Listen to the interviews with Dr David Collingridge (UK), Professor Benjamin Anderson (USA), Dr Ross Soo (Singapore) and Dr Donald Poon (Singapore).
|
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
18-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
17-May-2012
BioPharma Today
|
|
National Comprehensive Cancer Network, 2009
|
|
British Society of Gastroenterology, 2006
|
|
American Society of Clinical Oncology, 2007
|
|
European Society for Medical Oncology, 2009
|
|
European Society for Medical Oncology, 2009
|
|
